Treatment of cytomegalovirus optic neuritis with dihydroxy propoxymethyl guanine.
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D006150:Guanine Nucleotides / Q000627:therapeutic use*; D006157:Guanosine Monophosphate / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009902:Optic Neuritis / Q000188:drug therapy*
D000998:Antiviral Agents; D006150:Guanine Nucleotides; D006157:Guanosine Monophosphate; C043120:9-(1,3-dihydroxy-2-propoxymethyl)-GMP